![William Callahan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Callahan
Direttore/Membro del Consiglio presso MEDISUN PRECISION MEDICINE LTD.
Profilo
William Callahan is an Independent Director at Medisun Precision Medicine Ltd.
since 2015.
He was a Senior Director-Manufacturing Operations at Talphera, Inc. and a Vice President-Operations at Assertio Therapeutics, Inc. from 2002 to 2012.
He obtained an undergraduate degree from San Francisco State University.
Posizioni attive di William Callahan
Società | Posizione | Inizio |
---|---|---|
MEDISUN PRECISION MEDICINE LTD. | Direttore/Membro del Consiglio | 01/07/2015 |
Precedenti posizioni note di William Callahan
Società | Posizione | Fine |
---|---|---|
Assertio Therapeutics, Inc.
![]() Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Direttore operativo | 01/02/2012 |
TALPHERA, INC. | Corporate Officer/Principal | - |
Formazione di William Callahan
San Francisco State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
TALPHERA, INC. | Health Technology |
Aziende private | 2 |
---|---|
Assertio Therapeutics, Inc.
![]() Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Medisun Precision Medicine Ltd.
![]() Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |
- Borsa valori
- Insiders
- William Callahan